Attendees who purchased access to the 2016 Annual Meeting webcast were sent login information on May 11, 2016.

Login for full access:

Username and password are not your MyAACR account information

Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

Conference Years:

Days Within Meeting:

Conferences:

Availability:

Participation Type:

Presentations Access:

Presentation Access:

Topic Tracks*:

Organ Site Tracks*:

  • Sort by:
  • Browse by:
<< first | < prev page: of 7 records per page: next > | last >>
pages: 1 2 3 4 5 6 7 presentations: 1 to 25 of 175
Next Generation Sequencing (NGS)–Based Oncology Panels
Invited Speaker
Eunice Lee
U.S. Food and Drug Administration, Silver Spring, MD, United States
from AACR Annual Meeting 2016 on April 16, 2016 10:00 AM-11:00 AM
FDA Regulation of Companion and Complementary Diagnostics
Invited speaker
Pamela L. Bradley
U.S. Food and Drug Administration, Silver Spring, MD, United States
from AACR Annual Meeting 2016 on April 16, 2016 11:00 AM-12:00 PM
FDA Regulation of Companion and Complementary Diagnostics
Invited speaker
David Litwack
U.S. Food and Drug Administration, Silver Spring, MD, United States
from AACR Annual Meeting 2016 on April 16, 2016 11:00 AM-12:00 PM
FDA's Approach to Regulating Biosimilars
Invited Speaker
Darrell Abernethy
U.S. Food and Drug Administration, Silver Spring, MD, United States
from AACR Annual Meeting 2016 on April 16, 2016 1:00 PM-2:30 PM
FDA's Approach to Regulating Biosimilars
Invited Speaker
Leah Christl
U.S. Food and Drug Administration, Silver Spring, MD, United States
from AACR Annual Meeting 2016 on April 16, 2016 1:00 PM-2:30 PM
FDA's Approach to Regulating Biosimilars
Invited Speaker
Marjorie Shapiro
U.S. Food and Drug Administration, Silver Spring, MD, United States
from AACR Annual Meeting 2016 on April 16, 2016 1:00 PM-2:30 PM
FDA's Approach to Regulating Biosimilars
Invited Speaker
Tanya Wroblewski
U.S. Food and Drug Administration, Silver Spring, MD, United States
from AACR Annual Meeting 2016 on April 16, 2016 1:00 PM-2:30 PM
New FDA Initiatives in Personalized Medicine
Invited Speaker
Katherine Donigan
U.S. Food and Drug Administration, Silver Spring, MD, United States
from AACR Annual Meeting 2016 on April 16, 2016 3:00 PM-4:30 PM
New FDA Initiatives in Personalized Medicine
Invited Speaker
Laura Koontz
U.S. Food and Drug Administration, Silver Spring, MD, United States
from AACR Annual Meeting 2016 on April 16, 2016 3:00 PM-4:30 PM
Measurable Residual Disease Testing in the Hematological Malignancies
Introduction to measurable residual disease in the hematological malignancies
Christopher S. Hourigan
NHLBI, Bethesda, MD, United States
from AACR Annual Meeting 2016 on April 16, 2016 3:15 PM-5:15 PM
Measurable Residual Disease Testing in the Hematological Malignancies
Next-generation sequencing in the lymphoid malignancies
Aaron Logan
UCSF, San Francisco, CA, United States
from AACR Annual Meeting 2016 on April 16, 2016 3:15 PM-5:15 PM
Measurable Residual Disease Testing in the Hematological Malignancies
Flow cytometry in the myeloid malignancies
Roland B Walter
Fred Hutchinson Cancer Research Center, Seattle, WA, United States
from AACR Annual Meeting 2016 on April 16, 2016 3:15 PM-5:15 PM
Measurable Residual Disease Testing in the Hematological Malignancies
Regulatory aspects of MRD in clinical trials
Nicole J Gormley
U.S. Food and Drug Administration, Silver Spring, MD, United States
from AACR Annual Meeting 2016 on April 16, 2016 3:15 PM-5:15 PM
A Discussion of Early-Phase Expansion Cohort Trial Design in the Development of Future Oncology Products
Invited Speaker
Philippe L Bedard
Univ. of Toronto Univ. Health Network, Toronto, ON, Canada
from AACR Annual Meeting 2016 on April 17, 2016 1:00 PM-3:00 PM
A Discussion of Early-Phase Expansion Cohort Trial Design in the Development of Future Oncology Products
Invited speaker
Roy Jones
The University of Texas MD Anderson Cancer Center, Houston, TX, United States
from AACR Annual Meeting 2016 on April 17, 2016 1:00 PM-3:00 PM
A Discussion of Early-Phase Expansion Cohort Trial Design in the Development of Future Oncology Products
Invited Speaker
Samantha Roberts
Friends of Cancer Research, Washington, DC, United States
from AACR Annual Meeting 2016 on April 17, 2016 1:00 PM-3:00 PM
A Discussion of Early-Phase Expansion Cohort Trial Design in the Development of Future Oncology Products
Invited speaker
Eric H. Rubin
Merck Research Laboratories, North Wales, PA, United States
from AACR Annual Meeting 2016 on April 17, 2016 1:00 PM-3:00 PM
A Conversation with FDA Oncologic Drugs Advisory Committee (ODAC) Chairs
Richard Pazdur
U.S. Food and Drug Administration, Silver Spring, MD, United States
Deborah Armstrong
Johns Hopkins Kimmel Comprehensive Cancer Center, Baltimore, MD, United States
S Gail Eckhardt
University of Colorado Cancer Center, Aurora, CO, United States
Mikkael Sekeres
Cleveland Clinic, Cleveland, OH, United States
Wyndham E Wilson
National Cancer Institute, Bethesda, MD, United States
from AACR Annual Meeting 2016 on April 18, 2016 10:30 AM-12:30 PM
Update on Next Generation Sequencing (NGS) Technologies and the Precision Medicine Initiative (PMI)
Chairperson
Elaine R. Mardis
Washington University School Of Medicine, Saint Louis, MO, United States
from AACR Annual Meeting 2016 on April 18, 2016 10:30 AM-12:30 PM
Update on Next Generation Sequencing (NGS) Technologies and the Precision Medicine Initiative (PMI)
Invited speaker
David Litwack
U.S. Food and Drug Administration, Silver Spring, MD, United States
from AACR Annual Meeting 2016 on April 18, 2016 10:30 AM-12:30 PM
Update on Next Generation Sequencing (NGS) Technologies and the Precision Medicine Initiative (PMI)
Invited Speaker
Michael Berger
Memorial Sloan Kettering Cancer Center, New York, NY, United States
from AACR Annual Meeting 2016 on April 18, 2016 10:30 AM-12:30 PM
Update on Next Generation Sequencing (NGS) Technologies and the Precision Medicine Initiative (PMI)
Invited speaker
Girish Putcha
Palmetto GBA, SC, United States
from AACR Annual Meeting 2016 on April 18, 2016 10:30 AM-12:30 PM
Update on Next Generation Sequencing (NGS) Technologies and the Precision Medicine Initiative (PMI)
Invited Speaker
Charles L. Sawyers
Memorial Sloan Kettering Cancer Center, New York, NY, United States
from AACR Annual Meeting 2016 on April 18, 2016 10:30 AM-12:30 PM
Molecular Signatures for Adjuvant Treatment in Localized Prostate Cancer: Valued Assets or Expensive Conundrums
Invited speaker
Robert B. Den
Thomas Jefferson University Hospital, Philadelphia, PA, United States
from AACR Annual Meeting 2016 on April 18, 2016 5:00 PM-6:30 PM
Molecular Signatures for Adjuvant Treatment in Localized Prostate Cancer: Valued Assets or Expensive Conundrums
Invited speaker
Mark J. Ratain
University of Chicago, Chicago, IL, United States
from AACR Annual Meeting 2016 on April 18, 2016 5:00 PM-6:30 PM
<< first | < prev page: of 7 records per page: next > | last >>
pages: 1 2 3 4 5 6 7 presentations: 1 to 25 of 175